Keyphrases
Anticoagulation
100%
Rivaroxaban
41%
New York State
39%
Pulmonary Embolism
37%
Anticoagulant Therapy
35%
Pharmacist
27%
Warfarin
26%
Healthcare Professionals
24%
Anticoagulation Management Service
22%
Warfarin Therapy
20%
Adverse Drug Events
20%
At Discharge
20%
Stewardship
18%
Anticoagulation Stewardship
18%
National Board Certification
18%
Postpartum Period
18%
Pharmaceutics
18%
Bleeding Risk
18%
Hospital Pharmacist
18%
Managed Services
18%
Transitional Care
18%
International Normalized Ratio
18%
Rash
18%
Call to Action
18%
Novel Oral Anticoagulants
18%
Geriatric Population
18%
Drug Dependence
18%
Usual Care
18%
Adverse Effects
18%
Educational Program
18%
Clinical Competence
18%
Electronic Health Records
18%
Medical Care
18%
Anticoagulation Management
17%
Pharmacist-managed
17%
Drug Exposure
16%
Anticoagulants
15%
Deep Vein Thrombosis
14%
Emergency Department Visits
13%
Hospitalization
13%
Board Certification
12%
Ratio Values
11%
Anticoagulated Patients
11%
Direct Oral Anticoagulants
11%
Stewardship Program
9%
Simultaneous Administration
9%
Research Utility
9%
Total Drug
9%
Drug Effects
9%
Over-the-counter Drugs
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
52%
Warfarin
40%
Rivaroxaban
40%
Lung Embolism
37%
Anticoagulation Therapy
34%
Cholinergic Receptor Blocking Agent
18%
Rash
18%
Adverse Drug Reaction
17%
Deep Vein Thrombosis
14%
Pharmacokinetics
14%
Adverse Event
9%
Enoxaparin
9%
Pharmacodynamics
7%
Nursing and Health Professions
Anticoagulation
93%
Anticoagulant Therapy
24%
Warfarin
20%
Electronic Health Record
18%
International Normalized Ratio
18%
Emergency Ward
16%